Sierra Oncology, Inc. Common Stock
SRRA
SRRA was delisted on the 30th of June, 2022.
36 hedge funds and large institutions have $14.4M invested in Sierra Oncology, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 12 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less funds holding
Funds holding: 42 → 36 (-6)
23% less capital invested
Capital invested by funds: $18.7M → $14.4M (-$4.24M)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$779K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$395K |
| 3 |
D.E. Shaw & Co
New York
|
+$87.7K |
| 4 |
Millennium Management
New York
|
+$76.4K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$61.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$771K |
| 2 |
Renaissance Technologies
New York
|
-$411K |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$399K |
| 4 |
DM
Deerfield Management
New York
|
-$344K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$309K |
SRRA Hedge Fund Activity: Q4 2016 in Review
36 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Sierra Oncology, Inc. Common Stock (SRRA) for Q4 2016, worth a combined $14.4M — down 23% from $18.7M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of SRRA and 6 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 13 added.
The largest buyer was AWM Investment Company, opening a new position worth an estimated $779K. The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $771K sold.
- 36 institutional investors held Sierra Oncology, Inc. Common Stock (SRRA) as of Q4 2016, down from 42 in Q3 2016.
- Funds reported $14.4M of Sierra Oncology, Inc. Common Stock stock for Q4 2016, down 23% quarter-over-quarter.
- 6 funds opened new Sierra Oncology, Inc. Common Stock positions in Q4 2016 and 12 closed out, a net change of -6 holders.
- The largest Sierra Oncology, Inc. Common Stock buyer in Q4 2016 was AWM Investment Company, an estimated $779K added.
- The largest Sierra Oncology, Inc. Common Stock seller in Q4 2016 was BlackRock Fund Advisors, an estimated $771K sold.
Based on aggregated 13F filings for Q4 2016.